-
Featured
New Targeted Glioma Therapy Could Suppress Tumor Growth
Mass General has developed a genotype-targeted therapy for glioma, designed to be given at the tumor site during surgery, and an accompanying rapid diagnostic.
-
Featured
Surviving Gliomas Through Antibodies and Vaccination
Immunotherapy for glioma is under active investigation, but tumor-associated immunosuppression is a major obstacle. A Mass General team studied an investigational monoclonal antibody in mice with glioma, alone and in combination with tumor cell vaccination.
-
Featured
How Liquid Biopsy Could Improve Brain Tumor Treatment and Diagnoses
Mass General doctors are developing a liquid biopsy for brain tumors to reduce the need for invasive tissue biopsies.
-
Incidence of Malignant Brain and Spinal Tumors Varies Substantially by World Region
According to the first study of the global burden of malignant brain and spinal tumors, there is substantial variation between regions, with the greatest incidence estimated in Europe and North America and the lowest in Africa and Southeast Asia.
-
Review: Intraoperative MRI for Pituitary Adenomas
The use of magnetic resonance imaging during transsphenoidal surgery for pituitary adenomas provides images that allow detection of residual tumor and increase the likelihood of gross total resection.
-
Combined Blockade of ATR and PARP Effective Against Glioblastoma in Mice
The combination of olaparib and an ATR inhibitor was effective against glioblastoma in mice, providing a much-needed therapeutic breakthrough for this deadly disease.
Brain Tumor contributors
-
Bob S. Carter, MD, PhD
Chief, Neurosurgery Service
Recent Article
Multimodal Approach to Unruptured Cerebral Arteriovenous Malformations Tops ARUBA Outcomes
-
Brian V. Nahed, MD, MSc
Neurosurgical Oncology / Brain Tumor Surgeon / Mass General Brain Tumor Center, Neurosurgical Spinal Disorders, Associate Professor, Harvard Medical School
Associate Director Mass General Neurosurgery ProgramRecent Article
Incidence of Malignant Brain and Spinal Tumors Varies Substantially by World Region
-
-
William T. Curry, MD
Co-Director, Mass General Neuroscience , Director of Neurosurgical Oncology
Recent Article
New Approach to CAR T-Cell Therapy for Glioblastoma Aims to Circumvent Antigen Escape
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.Resource Links
